Symbicort 160 mikrograma/ 4,5 mikrograma po potisku, stlačeni inhalat, suspenzija
Name | Symbicort 160 mikrograma/ 4,5 mikrograma po potisku, stlačeni inhalat, suspenzija |
---|---|
Marketing Authorisation Number | HR-H-446429052 |
Active Substance | budezonid formoterolfumarat dihidrat |
Composition | jedna doza po potisku sadrži: 160 mikrograma budezonida po potisku i 4,5 mikrograma formoterolfumarat dihidrata po potisku |
Pharmaceutical Form | stlačeni inhalat, suspenzija |
Manufacturer | AstraZeneca Dunkerque Production, Dunkerque, Francuska |
Marketing Authorisation Holder | AstraZeneca d.o.o., Ulica Vjekoslava Heinzela 70, Zagreb, Hrvatska |
Marketing Authorisation Date | 26.01.2021 |
MA Period of Validity | unlimited |
Classification Number | UP/I-530-09/20-02/44 |
Registration Number | 381-12-01/30-21-03 |
Prescription | na recept |
Type of prescription | ponovljivi recept |
Distribution | u ljekarni |
Advertising to general public | zabranjeno |
ATC Code | R03AK07 |
Medicinal product marketed in the Croatia | Da |
SmPC | download |
PL | download |
Public Assessment Report | download |
Summary of risk management plan | download |